Aurora Cannabis Inc. (ACB.TO)
CAD 6.11
(-4.83%)
CAD 6.11
(-4.83%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 104.79 Million CAD | -53.94% |
| 2022 | 227.52 Million CAD | -15.57% |
| 2021 | 269.49 Million CAD | -32.55% |
| 2020 | 399.55 Million CAD | -24.79% |
| 2019 | 531.24 Million CAD | -17.61% |
| 2018 | 644.82 Million CAD | 217.32% |
| 2017 | 203.21 Million CAD | 218.08% |
| 2016 | 63.88 Million CAD | 509.23% |
| 2015 | 10.48 Million CAD | 25.28% |
| 2014 | 8.37 Million CAD | 1572.65% |
| 2013 | 500.43 Thousand CAD | 0.0% |
| 2012 | - CAD | 0.0% |
| 2011 | - CAD | 0.0% |
| 2010 | - CAD | 0.0% |
| 2009 | - CAD | 0.0% |
| 2008 | - CAD | 0.0% |
| 2007 | - CAD | 0.0% |
| 2006 | - CAD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 Q1 | 127.01 Million CAD | -18.78% |
| 2023 Q2 | 103.34 Million CAD | -18.64% |
| 2023 Q3 | 104.79 Million CAD | 1.4% |
| 2023 FY | 104.79 Million CAD | -53.94% |
| 2022 Q4 | 156.38 Million CAD | -31.27% |
| 2022 Q2 | 226.07 Million CAD | -30.56% |
| 2022 FY | 227.52 Million CAD | -15.57% |
| 2022 Q3 | 227.52 Million CAD | 0.64% |
| 2022 Q1 | 325.56 Million CAD | 20.81% |
| 2021 Q2 | 414.45 Million CAD | 1.89% |
| 2021 Q1 | 406.77 Million CAD | 1.81% |
| 2021 FY | 269.49 Million CAD | -32.55% |
| 2021 Q4 | 269.49 Million CAD | -30.57% |
| 2021 Q3 | 388.14 Million CAD | -6.35% |
| 2020 Q2 | 493.37 Million CAD | -2.7% |
| 2020 FY | 399.55 Million CAD | -24.79% |
| 2020 Q4 | 399.55 Million CAD | -16.92% |
| 2020 Q3 | 480.91 Million CAD | -2.52% |
| 2020 Q1 | 507.04 Million CAD | -4.56% |
| 2019 FY | 531.24 Million CAD | -17.61% |
| 2019 Q2 | 602.12 Million CAD | -24.33% |
| 2019 Q1 | 795.72 Million CAD | 23.4% |
| 2019 Q3 | 592.71 Million CAD | -1.56% |
| 2019 Q4 | 531.24 Million CAD | -10.37% |
| 2018 Q3 | 639.1 Million CAD | 83.88% |
| 2018 Q1 | 291.1 Million CAD | 43.25% |
| 2018 FY | 644.82 Million CAD | 217.32% |
| 2018 Q2 | 347.55 Million CAD | 19.39% |
| 2018 Q4 | 644.82 Million CAD | 0.9% |
| 2017 Q4 | 203.21 Million CAD | -2.85% |
| 2017 FY | 203.21 Million CAD | 218.08% |
| 2017 Q3 | 209.17 Million CAD | 65885.17% |
| 2017 Q2 | 317 Thousand CAD | -99.53% |
| 2017 Q1 | 66.91 Million CAD | 4.74% |
| 2016 Q4 | 63.88 Million CAD | 240.01% |
| 2016 Q1 | 13.52 Million CAD | 28.98% |
| 2016 Q2 | 20.61 Million CAD | 52.43% |
| 2016 Q3 | 18.78 Million CAD | -8.86% |
| 2016 FY | 63.88 Million CAD | 509.23% |
| 2015 Q2 | 9.39 Million CAD | 0.88% |
| 2015 Q1 | 9.3 Million CAD | 11.2% |
| 2015 FY | 10.48 Million CAD | 25.28% |
| 2015 Q4 | 10.48 Million CAD | 6.06% |
| 2015 Q3 | 9.88 Million CAD | 5.29% |
| 2014 Q2 | 2.38 Million CAD | 496.66% |
| 2014 FY | 8.37 Million CAD | 1572.65% |
| 2014 Q4 | 8.37 Million CAD | 240.19% |
| 2014 Q3 | 2.46 Million CAD | 3.1% |
| 2014 Q1 | 400 Thousand CAD | -20.07% |
| 2013 Q4 | 500.43 Thousand CAD | 0.0% |
| 2013 FY | 500.43 Thousand CAD | 0.0% |
| 2013 Q3 | - CAD | 0.0% |
| 2013 Q2 | - CAD | 0.0% |
| 2013 Q1 | - CAD | 0.0% |
| 2012 Q3 | - CAD | 0.0% |
| 2012 Q2 | - CAD | 0.0% |
| 2012 Q1 | - CAD | 0.0% |
| 2012 FY | - CAD | 0.0% |
| 2012 Q4 | - CAD | 0.0% |
| 2011 Q4 | - CAD | 0.0% |
| 2011 Q3 | - CAD | 0.0% |
| 2011 Q2 | - CAD | 0.0% |
| 2011 Q1 | - CAD | 0.0% |
| 2011 FY | - CAD | 0.0% |
| 2010 Q1 | - CAD | 0.0% |
| 2010 Q3 | - CAD | 0.0% |
| 2010 Q4 | - CAD | 0.0% |
| 2010 FY | - CAD | 0.0% |
| 2010 Q2 | - CAD | 0.0% |
| 2009 FY | - CAD | 0.0% |
| 2009 Q3 | - CAD | 0.0% |
| 2009 Q1 | - CAD | 0.0% |
| 2009 Q2 | - CAD | 0.0% |
| 2009 Q4 | - CAD | 0.0% |
| 2008 Q2 | - CAD | 0.0% |
| 2008 Q4 | - CAD | 0.0% |
| 2008 FY | - CAD | 0.0% |
| 2008 Q1 | - CAD | 0.0% |
| 2008 Q3 | - CAD | 0.0% |
| 2007 Q2 | - CAD | 0.0% |
| 2007 Q1 | - CAD | 0.0% |
| 2007 FY | - CAD | 0.0% |
| 2007 Q4 | - CAD | 0.0% |
| 2007 Q3 | - CAD | 0.0% |
| 2006 FY | - CAD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Avicanna Inc. | 1.8 Million CAD | -5710.756% |
| Avant Brands Inc. | 18.7 Million CAD | -460.32% |
| Cardiol Therapeutics Inc. | 158.53 Thousand CAD | -66000.85% |
| Crescita Therapeutics Inc. | 1.25 Million CAD | -8256.539% |
| Knight Therapeutics Inc. | 69.09 Million CAD | -51.671% |
| MediPharm Labs Corp. | 2.29 Million CAD | -4466.057% |
| OrganiGram Holdings Inc. | 155 Thousand CAD | -67507.097% |
| Canopy Growth Corporation | 683.17 Million CAD | 84.661% |
| Willow Biosciences Inc. | 2.15 Million CAD | -4760.436% |
| Auxly Cannabis Group Inc. | 159.04 Million CAD | 34.112% |